EVOLENT HEALTH INC - A (EVH) Stock Fundamental Analysis
USA - New York Stock Exchange - NYSE:EVH - US30050B1017 - Common Stock
3.94 USD
+0.04 (+1.03%)
3.99 USD
+0.05 (+1.27%)
EVH gets a fundamental rating of 2 out of 10. The analysis compared the fundamentals against 35 industry peers in the Health Care Technology industry. Both the profitability and financial health of EVH have multiple concerns. EVH is valied quite expensively at the moment, while it does show a decent growth rate.
1. Profitability
1.1 Basic Checks
- EVH had negative earnings in the past year.
- In the past year EVH has reported a negative cash flow from operations.
- EVH had negative earnings in each of the past 5 years.
- The reported operating cash flow has been mixed in the past 5 years: EVH reported negative operating cash flow in multiple years.
1.2 Ratios
- The Return On Assets of EVH (-7.37%) is better than 62.86% of its industry peers.
- EVH has a better Return On Equity (-21.48%) than 62.86% of its industry peers.
- Looking at the Return On Invested Capital, with a value of 0.68%, EVH is in line with its industry, outperforming 60.00% of the companies in the same industry.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | -7.37% | ||
| ROE | -21.48% | ||
| ROIC | 0.68% |
ROA(3y)-3.35%
ROA(5y)-7.41%
ROE(3y)-7.16%
ROE(5y)-16.17%
ROIC(3y)N/A
ROIC(5y)N/A
1.3 Margins
- Looking at the Operating Margin, with a value of 0.86%, EVH is in the better half of the industry, outperforming 65.71% of the companies in the same industry.
- EVH's Gross Margin of 18.42% is on the low side compared to the rest of the industry. EVH is outperformed by 85.71% of its industry peers.
- EVH's Gross Margin has declined in the last couple of years.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| OM | 0.86% | ||
| PM (TTM) | N/A | ||
| GM | 18.42% |
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-19.51%
GM growth 5Y-10.71%
2. Health
2.1 Basic Checks
- The Return on Invested Capital (ROIC) is below the Cost of Capital (WACC), so EVH is destroying value.
- Compared to 1 year ago, EVH has more shares outstanding
- The number of shares outstanding for EVH has been increased compared to 5 years ago.
- EVH has a worse debt/assets ratio than last year.
2.2 Solvency
- EVH has an Altman-Z score of 0.59. This is a bad value and indicates that EVH is not financially healthy and even has some risk of bankruptcy.
- EVH has a Altman-Z score (0.59) which is comparable to the rest of the industry.
- EVH has a Debt/Equity ratio of 1.26. This is a high value indicating a heavy dependency on external financing.
- EVH has a Debt to Equity ratio of 1.26. This is amonst the worse of the industry: EVH underperforms 88.57% of its industry peers.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 1.26 | ||
| Debt/FCF | N/A | ||
| Altman-Z | 0.59 |
ROIC/WACC0.09
WACC7.97%
2.3 Liquidity
- EVH has a Current Ratio of 1.33. This is a normal value and indicates that EVH is financially healthy and should not expect problems in meeting its short term obligations.
- Looking at the Current ratio, with a value of 1.33, EVH is doing worse than 65.71% of the companies in the same industry.
- A Quick Ratio of 1.33 indicates that EVH should not have too much problems paying its short term obligations.
- EVH's Quick ratio of 1.33 is on the low side compared to the rest of the industry. EVH is outperformed by 65.71% of its industry peers.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Current Ratio | 1.33 | ||
| Quick Ratio | 1.33 |
3. Growth
3.1 Past
- The earnings per share for EVH have decreased strongly by -101.10% in the last year.
- The Earnings Per Share has been growing by 220.75% on average over the past years. This is a very strong growth
- Looking at the last year, EVH shows a very negative growth in Revenue. The Revenue has decreased by -16.65% in the last year.
- Measured over the past years, EVH shows a very strong growth in Revenue. The Revenue has been growing by 30.04% on average per year.
EPS 1Y (TTM)-101.1%
EPS 3Y220.75%
EPS 5YN/A
EPS Q2Q%25%
Revenue 1Y (TTM)-16.65%
Revenue growth 3Y41.17%
Revenue growth 5Y30.04%
Sales Q2Q%-22.83%
3.2 Future
- EVH is expected to show a small growth in Earnings Per Share. In the coming years, the EPS will grow by 8.00% yearly.
- EVH is expected to show a small growth in Revenue. In the coming years, the Revenue will grow by 6.63% yearly.
EPS Next Y-88.84%
EPS Next 2Y-26.91%
EPS Next 3Y-7.47%
EPS Next 5Y8%
Revenue Next Year-26.69%
Revenue Next 2Y-3.16%
Revenue Next 3Y2.01%
Revenue Next 5Y6.63%
3.3 Evolution
- The EPS growth rate is decreasing: in the next years the growth will be less than in the last years.
- The Revenue growth rate is decreasing: in the next years the growth will be less than in the last years.
4. Valuation
4.1 Price/Earnings Ratio
- EVH reported negative earnings for the last year, which makes the Price/Earnings Ratio negative.
- A Price/Forward Earnings ratio of 11.18 indicates a reasonable valuation of EVH.
- Compared to the rest of the industry, the Price/Forward Earnings ratio of EVH indicates a rather cheap valuation: EVH is cheaper than 88.57% of the companies listed in the same industry.
- EVH is valuated cheaply when we compare the Price/Forward Earnings ratio to 24.31, which is the current average of the S&P500 Index.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | N/A | ||
| Fwd PE | 11.18 |
4.2 Price Multiples
- Based on the Enterprise Value to EBITDA ratio, EVH is valued a bit cheaper than the industry average as 80.00% of the companies are valued more expensively.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| P/FCF | N/A | ||
| EV/EBITDA | 11.71 |
4.3 Compensation for Growth
- EVH's earnings are expected to decrease with -7.47% in the coming years. This may justify a cheaper valuation.
PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y-26.91%
EPS Next 3Y-7.47%
5. Dividend
5.1 Amount
- No dividends for EVH!.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | 0% |
3.94
+0.04 (+1.03%)
Chartmill FA Rating
GICS SectorHealth Care
GICS IndustryGroupHealth Care Equipment & Services
GICS IndustryHealth Care Technology
Earnings (Last)11-06 2025-11-06/amc
Earnings (Next)02-18 2026-02-18/amc
Inst Owners124.12%
Inst Owner Change0.17%
Ins Owners1.56%
Ins Owner Change3.91%
Market Cap439.70M
Revenue(TTM)2.05B
Net Income(TTM)-180.88M
Analysts85.26
Price Target10.38 (163.45%)
Short Float %17.81%
Short Ratio4.97
Dividend
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | 0% |
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)0
Avg EPS beat(2)-139.54%
Min EPS beat(2)-226.45%
Max EPS beat(2)-52.63%
EPS beat(4)0
Avg EPS beat(4)-162.45%
Min EPS beat(4)-332.96%
Max EPS beat(4)-37.77%
EPS beat(8)3
Avg EPS beat(8)-78.52%
EPS beat(12)6
Avg EPS beat(12)-25.77%
EPS beat(16)10
Avg EPS beat(16)442.42%
Revenue beat(2)1
Avg Revenue beat(2)-1.34%
Min Revenue beat(2)-4.24%
Max Revenue beat(2)1.56%
Revenue beat(4)2
Avg Revenue beat(4)-0.09%
Min Revenue beat(4)-4.24%
Max Revenue beat(4)4.03%
Revenue beat(8)5
Avg Revenue beat(8)0.67%
Revenue beat(12)7
Avg Revenue beat(12)0.38%
Revenue beat(16)10
Avg Revenue beat(16)1.03%
PT rev (1m)0%
PT rev (3m)-35.03%
EPS NQ rev (1m)0%
EPS NQ rev (3m)-55.1%
EPS NY rev (1m)-22.22%
EPS NY rev (3m)-70.11%
Revenue NQ rev (1m)0%
Revenue NQ rev (3m)-2.56%
Revenue NY rev (1m)0%
Revenue NY rev (3m)-0.42%
Valuation
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | N/A | ||
| Fwd PE | 11.18 | ||
| P/S | 0.21 | ||
| P/FCF | N/A | ||
| P/OCF | N/A | ||
| P/B | 0.52 | ||
| P/tB | N/A | ||
| EV/EBITDA | 11.71 |
EPS(TTM)-0.01
EYN/A
EPS(NY)0.35
Fwd EY8.95%
FCF(TTM)-0.62
FCFYN/A
OCF(TTM)-0.32
OCFYN/A
SpS18.41
BVpS7.55
TBVpS-7.68
PEG (NY)N/A
PEG (5Y)N/A
Graham NumberN/A
Profitability
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | -7.37% | ||
| ROE | -21.48% | ||
| ROCE | 0.87% | ||
| ROIC | 0.68% | ||
| ROICexc | 0.73% | ||
| ROICexgc | 6.52% | ||
| OM | 0.86% | ||
| PM (TTM) | N/A | ||
| GM | 18.42% | ||
| FCFM | N/A |
ROA(3y)-3.35%
ROA(5y)-7.41%
ROE(3y)-7.16%
ROE(5y)-16.17%
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexgc growth 3YN/A
ROICexgc growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-19.51%
GM growth 5Y-10.71%
F-Score4
Asset Turnover0.84
Health
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 1.26 | ||
| Debt/FCF | N/A | ||
| Debt/EBITDA | 9.01 | ||
| Cap/Depr | 32.44% | ||
| Cap/Sales | 1.58% | ||
| Interest Coverage | N/A | ||
| Cash Conversion | N/A | ||
| Profit Quality | N/A | ||
| Current Ratio | 1.33 | ||
| Quick Ratio | 1.33 | ||
| Altman-Z | 0.59 |
F-Score4
WACC7.97%
ROIC/WACC0.09
Cap/Depr(3y)38.35%
Cap/Depr(5y)41.66%
Cap/Sales(3y)1.98%
Cap/Sales(5y)2.43%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)-101.1%
EPS 3Y220.75%
EPS 5YN/A
EPS Q2Q%25%
EPS Next Y-88.84%
EPS Next 2Y-26.91%
EPS Next 3Y-7.47%
EPS Next 5Y8%
Revenue 1Y (TTM)-16.65%
Revenue growth 3Y41.17%
Revenue growth 5Y30.04%
Sales Q2Q%-22.83%
Revenue Next Year-26.69%
Revenue Next 2Y-3.16%
Revenue Next 3Y2.01%
Revenue Next 5Y6.63%
EBIT growth 1Y218.14%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next Year297.61%
EBIT Next 3Y71.11%
EBIT Next 5Y48.15%
FCF growth 1Y-223.81%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y-140.71%
OCF growth 3Y-21.47%
OCF growth 5YN/A
EVOLENT HEALTH INC - A / EVH FAQ
What is the fundamental rating for EVH stock?
ChartMill assigns a fundamental rating of 2 / 10 to EVH.
Can you provide the valuation status for EVOLENT HEALTH INC - A?
ChartMill assigns a valuation rating of 3 / 10 to EVOLENT HEALTH INC - A (EVH). This can be considered as Overvalued.
Can you provide the profitability details for EVOLENT HEALTH INC - A?
EVOLENT HEALTH INC - A (EVH) has a profitability rating of 2 / 10.
Can you provide the financial health for EVH stock?
The financial health rating of EVOLENT HEALTH INC - A (EVH) is 1 / 10.